However, it should not be seen as a replacement for prescription medications like Ozempic
46 That dedicated kidney outcomes study, involving over 3500 patients with both T2D and established chronic kidney disease, demonstrated that once-weekly subcutaneous semaglutide 1.0 mg significantly reduced the primary composite renal outcome (including kidney failure onset, a 50% persistent decline in estimated glomerular filtration rate (eGFR), or renal/cardiovascular death) compared with placebo
Fourth, although all patients had documented weight reduction, the magnitude and rate of weight loss were not quantified, and lifestyle-related factors such as diet and exercise were unavailable
Tirzepatide is a dual-action GLP-1 and GIP receptor agonist that helps regulate blood sugar and appetite when injected subcutaneously, and your thigh is one of the most accessible and comfortable injection sites for consistent weekly dosing
Benefits Works to neutralize free radicals and reduce oxidative damage while giving your liver the support it needs for natural detoxification
